Literature DB >> 16077066

New drugs target hypoxia response in tumors.

Ken Garber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16077066     DOI: 10.1093/jnci/dji261

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Estrogen suppresses cardiac IL-6 after trauma-hemorrhage via a hypoxia-inducible factor 1 alpha-mediated pathway.

Authors:  Eike A Nickel; Chi-Hsun Hsieh; Jianguo G Chen; Martin G Schwacha; Irshad H Chaudry
Journal:  Shock       Date:  2009-04       Impact factor: 3.454

2.  Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine sponges.

Authors:  Tawnya C McKee; Daniel Rabe; Heidi R Bokesch; Tanja Grkovic; Emily L Whitson; Thushara Diyabalanage; Albert W W Van Wyk; Stephanie R Marcum; Roberta S Gardella; Kirk R Gustafson; W Marston Linehan; James B McMahon; Donald P Bottaro
Journal:  J Nat Prod       Date:  2012-08-28       Impact factor: 4.050

3.  Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells.

Authors:  Ke Liang; Songbo Qiu; Yang Lu; Zhen Fan
Journal:  Cancer Biol Ther       Date:  2013-10-22       Impact factor: 4.742

Review 4.  Pleiotropic Role of Puupehenones in Biomedical Research.

Authors:  Beatriz Martínez-Poveda; Ana R Quesada; Miguel Ángel Medina
Journal:  Mar Drugs       Date:  2017-10-21       Impact factor: 5.118

5.  Identification of small molecule compounds that inhibit the HIF-1 signaling pathway.

Authors:  Menghang Xia; Kun Bi; Ruili Huang; Ming-Hsuang Cho; Srilatha Sakamuru; Susanne C Miller; Hua Li; Yi Sun; John Printen; Christopher P Austin; James Inglese
Journal:  Mol Cancer       Date:  2009-12-09       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.